カレンダーに戻る
イベント詳細
2011年 07月 21日(木)
イベント
午後07:00 - 午後09:00
Kyowa Pharmaceutical - The Turnaround Story (Kansai Event)
お申し込み・キャンセル期限: 2011年 07月 19日(火)
スピーカー: Hiroshi Kobayashi (Chief Financial Officer, Kyowa Pharmaceutical Industry Co. Ltd), Satyajit Atwe
Hosting Committee(s): Kansai - Business Programs
会場: ANA Crowne Plaza Osaka
Member Fee: ¥5000
Guest Fee: ¥6500
Event overview:
A large Indian pharmaceutical company and a family owned Japanese company in the traditionally conservative generic drug industry come together…..…
makings of a cultural clash? Or a well planned acquisition?
Join us for a special presentation from Hiroshi Kobayashi and Satyajit Atwe as they navigate us through the deal. Find out about the reasons behind the acquisition, how they did it and how things have been post acquisition. For those in the industry, a must see insight into this unique business case and for those not, a fascinating chance to learn about the clash between two very different cultures and how one company dealt with this.
Speaker Profile:
Hiroshi Kobayashi
After graduating form Kyoto University in Economics, Mr.Kobayashi started his career in the logistics field with a large Japanese manufacturing company before starting his finance career. He has a wide range of experience from investor relations, to business planning & analysis and now heads up the Finance & IT Department of Kyowa Pharmaceuticals here in their Osaka Headquarters where he is also a board member. Prior to joining Kyowa he was working at Novartis with various roles in finance as well as the role of running Six Sigma initiatives. Mr.Kobayashi also attended London Business School where he obtained his MBA.
Satyajit Atwe
Mr. Atwe originally hails from India but has extensive business experience stretching across many parts of the Asia Pacific Region. His current post with Lupin, one of India’s largest generic drug companies has brought him here to Japan where he currently overseas the Strategic Planning Department of Kyowa Pharmaceuticals. Mr. Atwe was instrumental in the purchase of Kyowa Pharmaceuticals by Lupin in 2007. Prior to joining Lupin in 2006, Mr. Atwe held management positions at two other large Indian pharmaceutical companies, namely, Dr. Reddy and Ranbaxy and has experience encompassing sales, business development, licensing and strategic implementation. He has an MBA and is well known for his constant “quest for knowledge” which is clearly illustrated in everything that he does.
A large Indian pharmaceutical company and a family owned Japanese company in the traditionally conservative generic drug industry come together…..…
makings of a cultural clash? Or a well planned acquisition?
Join us for a special presentation from Hiroshi Kobayashi and Satyajit Atwe as they navigate us through the deal. Find out about the reasons behind the acquisition, how they did it and how things have been post acquisition. For those in the industry, a must see insight into this unique business case and for those not, a fascinating chance to learn about the clash between two very different cultures and how one company dealt with this.
Speaker Profile:
Hiroshi Kobayashi
After graduating form Kyoto University in Economics, Mr.Kobayashi started his career in the logistics field with a large Japanese manufacturing company before starting his finance career. He has a wide range of experience from investor relations, to business planning & analysis and now heads up the Finance & IT Department of Kyowa Pharmaceuticals here in their Osaka Headquarters where he is also a board member. Prior to joining Kyowa he was working at Novartis with various roles in finance as well as the role of running Six Sigma initiatives. Mr.Kobayashi also attended London Business School where he obtained his MBA.
Satyajit Atwe
Mr. Atwe originally hails from India but has extensive business experience stretching across many parts of the Asia Pacific Region. His current post with Lupin, one of India’s largest generic drug companies has brought him here to Japan where he currently overseas the Strategic Planning Department of Kyowa Pharmaceuticals. Mr. Atwe was instrumental in the purchase of Kyowa Pharmaceuticals by Lupin in 2007. Prior to joining Lupin in 2006, Mr. Atwe held management positions at two other large Indian pharmaceutical companies, namely, Dr. Reddy and Ranbaxy and has experience encompassing sales, business development, licensing and strategic implementation. He has an MBA and is well known for his constant “quest for knowledge” which is clearly illustrated in everything that he does.
Note: ACCJ events are for ACCJ members and their guests only. To learn more about becoming an ACCJ member, see the Membership section of this site or contact the Membership Services Department at info@accj.or.jp / (03) 3433-7304.
